Enteric-coated aspirin is less effective than plain aspirin for preventing cardiovascular events.

  Several studies suggest that enteric-coated aspirin doesn't inhibit platelet aggregations as well as plain aspirin. Researchers speculate that enteric-coated aspirin might not be absorbed as well as plain aspirin in some patients.

  But so far, studies have only looked at measures of platelet function...NOT long-term outcomes. Plus, other research shows that enteric coated aspirin and plain aspirin are equally effective in inhibiting platelet aggregation.

  Tell people there's no proof that enteric-coated aspirin is less effective that plain aspirin for reducing the risk of heart attacks and strokes.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote